Medication Adherence News and Research

RSS
Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy

Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy

Consumers roundup: More patients choose high-deductible plans; Many neglect doctors medication directions

Consumers roundup: More patients choose high-deductible plans; Many neglect doctors medication directions

Non-adherence to medication increases risk of falling in older adults

Non-adherence to medication increases risk of falling in older adults

Long-term smoking cessation success possible with treatment philosophy and individualized information

Long-term smoking cessation success possible with treatment philosophy and individualized information

eMedonline telemonitoring system developed to help patients transition from inpatient to outpatient setting

eMedonline telemonitoring system developed to help patients transition from inpatient to outpatient setting

Adults with SCA show poorer performance on neurocognitive tests: Study

Adults with SCA show poorer performance on neurocognitive tests: Study

Prescription costs more likely to keep Hispanics away from pharmacy counter: Study

Prescription costs more likely to keep Hispanics away from pharmacy counter: Study

Negative impact of depression on glycemic control in type 2 diabetes patients

Negative impact of depression on glycemic control in type 2 diabetes patients

Study investigates pilot VBBD program to improve adherence to diabetes medications

Study investigates pilot VBBD program to improve adherence to diabetes medications

Hartford Foundation awards $800,000 grant for training in geriatric social work

Hartford Foundation awards $800,000 grant for training in geriatric social work

CVS Caremark survey results of specialty pharmacy patients

CVS Caremark survey results of specialty pharmacy patients

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

BioTrends Research Group, NKF publish Special Report on patients with CKD

BioTrends Research Group, NKF publish Special Report on patients with CKD

Data illustrates methods for improving adherence to medication, lowering prescription drug costs

Data illustrates methods for improving adherence to medication, lowering prescription drug costs

Catalyst Pharmaceutical Partners reports net loss of $7.24M for fourth-quarter 2009

Catalyst Pharmaceutical Partners reports net loss of $7.24M for fourth-quarter 2009

Ensuring medication compliance in clinical trials: Pill capsules with microchips to signal ingestion

Ensuring medication compliance in clinical trials: Pill capsules with microchips to signal ingestion

Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting

Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting

CVS/pharmacy to help consumers dispose unwanted medication in an effort to protect the environment

CVS/pharmacy to help consumers dispose unwanted medication in an effort to protect the environment

Health care reform bill includes provisions for MTM programs, says Arcadia Resources

Health care reform bill includes provisions for MTM programs, says Arcadia Resources

Publix Pharmacies launches first phase of new diabetes management system

Publix Pharmacies launches first phase of new diabetes management system

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.